EuroPCR 2018: Medtronic touts BP reductions, no major adverse events in renal denervation trial

EuroPCR 2018: Medtronic touts BP reductions, no major adverse events in renal denervation trial  Mass Device PCR statement on device-based therapies for hypertension  European Society of Cardiology (press release) New Medtronic Data Show Significant Blood Pressure Lowering Effect of Renal Denervation in Patients Taking Anti ...  Press of Atlantic CityFull coverage

Read More ...
EuroPCR 2018: Medtronic touts BP reductions, no major adverse events in renal denervation trial published May 23, 2018 at 08:47PM. Original Source Link : https://www.massdevice.com/europcr-2018-medtronic-touts-bp-reductions-no-major-adverse-events-in-renal-denervation-trial/

loading...